wes is one of the ones I hope takes a bit of a hit with the downturn. I've been close to buying it a couple of times over the last 12 months but been a bit greedy so far.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%